dermatology-summit-wound-care-2019-posters

8 / 15

allied
academies
Page 58
September 09-10, 2019 | Edinburgh, Scotland
2nd Global Summit on
3rd International Conference on
Dermatology and Cosmetology
Wound Care, Tissue Repair and Regenerative Medicine
Joint Event
&
Journal of Dermatology Research and Skin Care | Volume 3
Dermatol Res Skin Care, Volume 3
A Look at placental tissue allografts in wound healing and musculoskeletal injuries:
Protocols for successful outcomes
Bruce Werber
BioStem Life Sciences, USA
Musculoskeletal trauma and wound healing acceleration
utilizing Rheo, a cryopreserved amniotic fluid,
Wharton’s jelly, Extra-Cellular Matrix (ECM) allograft,
minimally manipulated via the AnuSureTech proprietary
process.
Maintaining the functionality of healthy placental tissue
containing extracellular matrix and bioactive cytokines
(growth factors, chemokines), intracellular messengers
(miRNA, Exosomes) and cellular components in a
cryopreserved injectable allograft. It is the combination of
the amniotic fluid, cellular components, Wharton’s jelly,
ECM, cytokines producing a immunomodulatory, and anti-
inflammatory effect. That enhances the recipients, tissue
regenerative ability and providing significant value in pain
control, orthopedic pathologies, organ system pathologies.
The bioassay results presented in this paper demonstrate
that the AnuSureTech process is a significant advancement in
placental tissue processing providing high levels of cytokines,
growth factors, cellular components andECMafter processing
and sterilization.
Case study discussion of specific protocols to utilize this
regenerative allograft in order to achieve optimal success
in a variety of orthopedic, wound and cosmetic indications.
Allowing their use in regenerative medicine highly effective
and safe.
e: